Financial News
Latest News about LLY
Recent news which mentions LLY
From Benzinga
From Motley Fool
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
August 04, 2021
From Benzinga
If You Invested $24,370 in This Top Stock 5 Years Ago, You'd Be Making $1,000 in Dividends This Year
August 04, 2021
Tickers
LLY
From Motley Fool
Eli Lilly and Company (LLY) Q2 2021 Earnings Call Transcript
August 03, 2021
Tickers
LLY
From Motley Fool
4 Top Stock Trades for Wednesday: Ethereum, Bitcoin, LLY, HOOD
August 03, 2021
From InvestorPlace
Another Big Earnings Week Ahead
August 03, 2021
From Benzinga
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
August 03, 2021
From Benzinga
Lilly Stock Slips On Mixed Bag Q2 Earnings, Cuts FY21 Sales Outlook For COVID-19 Therapies
August 03, 2021
Tickers
LLY
From Benzinga
A Peek Into The Markets: US Stock Futures Gain Ahead Of Earnings
August 03, 2021
From Benzinga
5 Stocks To Watch For August 3, 2021
August 03, 2021
From Benzinga
Investors Should Avoid High-Risk Atossa Therapeutics
August 02, 2021
From InvestorPlace
Videogames entered the mainstream in the pandemic, but the industry faces a rough transition
August 01, 2021
From MarketWatch
Biogen: Does Aduhelm Make it the Next Dendreon?
July 30, 2021
From InvestorPlace
Lilly's Donanemab Lowers Alzheimer's-Associated Biomarkers In Patients With Early Disease
July 30, 2021
Tickers
LLY
From Benzinga
Why Biogen's Stock Has Likely Peaked
July 30, 2021
From Motley Fool
Eli Lilly-Incyte's Rheumatoid Arthritis Drug Gets OK From FDA For Solo Use In Hospitalized COVID-19 Patients
July 29, 2021
From Benzinga
From Benzinga
From Motley Fool
3 Biotech Stocks That Could Rocket Higher
July 24, 2021
From Motley Fool
Stocks That Hit 52-Week Highs On Friday
July 23, 2021
From Benzinga
From Benzinga
3 Biotechs That Could Make Big Acquisitions This Year
July 22, 2021
From Motley Fool
From Motley Fool
2 Compelling Reasons to Buy This Reawakened Pharma Giant
July 19, 2021
From Motley Fool
The Week Ahead In Biotech: Earnings Kickstart With J&J And Biogen, Albireo Awaits FDA Decisions, More IPOs
July 18, 2021
From Benzinga
Tickers
LLY
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.